After statistical analysis, neither CK19, CDH17, nor GPC3 was found to be a significantly poor prognostic factor for disease-free survival (DFS) or overall survival (OS) (P all > 0.05) in N-HCC (Figure 5). This evidence concerns the gene GPC3 and hepatocellular carcinoma.